P. Heutink < P. J. Bedard < P. J. Blanchet

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 47.
[0-20] [0 - 20][0 - 47][20-40]

Ident.	Authors (with country if any)	Title
000022 (2000)	F. Calon [Canada] ; R. Grondin [Canada] ; M. Morissette [Canada] ; M. Goulet [Canada] ; P. J. Blanchet [Canada] ; T. T. Di Paolo [Canada] ; P. J. Bedard [Canada]	Molecular basis of levodopa-induced dyskinesias
000035 (2000)	M. Goulet [Canada] ; R. Grondin [Canada] ; M. Morissette [Canada] ; S. Maltais [Canada] ; P. Falardeau [Canada] ; P. J. Bedard [Canada] ; T. Di Paolo [Canada]	Regulation by chronic treatment with cabergoline of dopamine D1 and D2 receptor levels and their expression in the striatum of Parkinsonian-Monkeys
000039 (2000)	F. Calon [Canada] ; M. Morissette [Canada] ; M. Goulet [Canada] ; R. Grondin [Canada] ; P. J. Blanchet [Canada] ; P. J. Bedard [Canada] ; T. Di Paolo [Canada]	125I-CGP 64213 binding to GABAB receptors in the brain of monkeys : Effect of MPTP and dopaminomimetic treatments
000043 (2000)	ABDALLAH HADJ TAHAR [Canada] ; N. Belanger [Canada] ; E. Bangassoro [Canada] ; L. Gregoire [Canada] ; P. J. Bedard [Canada]	Antidyskinetic effect of JL-18, a clozapine analog, in parkinsonian monkeys
000265 (2003)	A. Hadj Tahar [Canada] ; R. Grondin [Canada] ; L. Gregoire [Canada] ; F. Calon [Canada] ; T. Di Paolo [Canada] ; P. J. Bedard [Canada]	New insights in Parkinson's disease therapy: Can levodopa-induced dyskinesia ever be manageable
000C45 (1986)	P. J. Bedard ; T. Di Paolo ; P. Falardeau ; R. Boucher	Chronic treatment with L-DOPA, but not bromocriptine induces dyskinesia in MPTP-Parkinsonian monkeys. Correlation with [3H]spiperone binding
000C97 (1988)	M. Filion ; L. Tremblay ; P. J. Bedard	Abnormal influences of passive limb movement on the activity of globus pallidus neurons in parkinsonian monkeys
000D05 (1988)	P. Falardeau ; S. Bouchard ; P. J. Bedard ; R. Boucher ; T. Di Paolo	Behavioral and biochemical effect of chronic treatment with D-1 and/or D-2dopamine agonists in MPTP monkeys
000D30 (1989)	P. J. Bedard ; R. Boucher	Effect of D1 receptor stimulation in normal and MPTP monkeys
000D34 (1989)	L. Tremblay ; M. Filion ; P. J. Bedard	Responses of pallidal neurons to striatal stimulation in monkeys with MPTP-induced parkinsonism
000D41 (1990)	C. Gagnon ; P. J. Bedard ; T. Di Paolo	Effect of chronic treatment of MPTP monkeys with dopamine D-1 and/or D-2 receptor agonists
000D42 (1990)	C. Rouillard ; P. J. Bedard ; T. Di Paolo	Effects of chronic treatment of MPTP monkeys with bromocriptine alone or in combination with SKF 38393
000D84 (1991)	M. Filion ; L. Tremblay ; P. J. Bedard	Effects of dopamine agonists on the spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism
000D92 (1991)	B. Gomez-Mancilla [Canada] ; R. Boucher ; P. J. Bedard	Effect of clonidine and atropine on rest tremor in the MPTP monkey model of parkinsonism
000D95 (1991)	B. Gomez-Mancilla [Canada] ; P. J. Bedard	Effect of D1 and D2 agonists and antagonists on dyskinesia produced by L-DOPA in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys
000E04 (1992)	B. Gomez-Mancilla [Canada] ; R. Boucher ; P. J. Bedard	Effect of LY 171555 and CY 208-243 on tremor suppression in the MPTP monkey model of Parkinsonism
000E09 (1992)	E. Pourcher [Canada] ; B. Gomez-Mancilla ; P. J. Bedard	Ethosuximide and tremor in Parkinson's disease : a pilot study
000E10 (1992)	B. Gomez-Mancilla [Canada] ; J.-F. Latulippe ; R. Boucher ; P. J. Bedard	Effect of ethosuximide on rest tremor in the MPTP monkey model
000E45 (1992)	B. Gomez-Mancilla [Canada] ; P. J. Bedard	Effect of chronic treatment with (+)-PHNO, a D2 agonist in MPTP-treated monkeys
000E74 (1993)	B. Gomez-Mancilla [Canada] ; R. Boucher ; C. Gagnon ; T. Di Paolo ; R. Markstein ; P. J. Bedard	Effect of adding the D1 agonist CY 208-243 to chronic bromocriptine treatment. I: Evaluation of motor parameters in relation to striatal catecholamine content and dopamine receptors
000E85 (1993)	L. Rioux [Canada] ; C. Gagnon ; D. P. Gaudin [Canada] ; T. Di Paolo ; P. J. Bedard [Canada]	A fetal nigral graft prevents behavioral supersensitivity associated with repeated injections of L-dopa in 6-OHDA rats. Correlation with D1 and D2 receptors

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PascalFrancis/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/Author.i -k "P. J. Bedard" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/Author.i  \
                -Sk "P. J. Bedard" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    indexItem
   |index=    Author.i
   |clé=    P. J. Bedard
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022